These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2285341)

  • 1. [Method for developing a controlled process. Study of the possible regulation of rifamycin B biosynthesis].
    Kuz'mina LM; Krasnova TP; Lysko AV; Vostrikova VN; Rychkov AE; Kolesnikova NA; Mal'tsev NI
    Antibiot Khimioter; 1990 Jul; 35(7):5-8. PubMed ID: 2285341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A method for developing a controlled process. Development and execution of a program supplying culture medium components for rifamycin B biosynthesis].
    Kuz'mina LM; Krasnova TP; Lysko AV; Vostrikova VN; Bushueva OA; Mal'tsev NI
    Antibiot Khimioter; 1990 Jul; 35(7):8-12. PubMed ID: 2285343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of various forms of inorganic nitrogen on the biosynthesis of rifamycin B].
    Lysko AV; Gorskaia SV
    Antibiot Med Biotekhnol; 1986 Jul; 31(7):519-21. PubMed ID: 3767329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. I. Isolation and characterization of a pentose-excreting auxotrophic mutant of Nocardia mediterranei with drastically reduced rifamycin production.
    Ghisalba O; Nüesch J
    J Antibiot (Tokyo); 1978 Mar; 31(3):202-14. PubMed ID: 649515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of mycelium morphological characteristics and rifamycin B production using Nocardia mediterranei.
    Lee KJ; Rho YT
    J Biotechnol; 1994 Aug; 36(3):239-45. PubMed ID: 7765266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. II. Isolation and characterization of a shikimate excreting auxotrophic mutant of Nocardia mediterranei with normal rifamycin-production.
    Ghisalba O; Nüesch J
    J Antibiot (Tokyo); 1978 Mar; 31(3):215-25. PubMed ID: 649516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structured kinetic model to represent the utilization of multiple substrates in complex media during rifamycin B fermentation.
    Bapat PM; Bhartiya S; Venkatesh KV; Wangikar PP
    Biotechnol Bioeng; 2006 Mar; 93(4):779-90. PubMed ID: 16302259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The route of incorporation of nitrogen atom into rifamycin during its biosynthesis.
    Jiao RS; Liu CJ; Jin ZK; Zhang XC; Ni LY; Lu ZM
    Sci Sin B; 1984 Apr; 27(4):380-90. PubMed ID: 6147017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of low molecular weight regulators on the biosynthesis of rifamycin B by Amycolatopsis mediterranei strains].
    Bushueva OA; Efremenkova OV; Gorin SE; Bartoshevich IuE
    Antibiot Khimioter; 1991 Mar; 36(3):11-5. PubMed ID: 1877868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of B-factor and its analogues on rifamycin biosynthesis in Nocardia sp.
    Kawaguchi T; Azuma M; Horinouchi S; Beppu T
    J Antibiot (Tokyo); 1988 Mar; 41(3):360-5. PubMed ID: 3366694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New rifamycins produced by a recombinant strain of Nocardia mediterranei.
    Schupp T; Traxler P; Auden JA
    J Antibiot (Tokyo); 1981 Aug; 34(8):965-70. PubMed ID: 7319929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase shifts in the stoichiometry of rifamycin B fermentation and correlation with the trends in the parameters measured online.
    Bapat PM; Das D; Dave NN; Wangikar PP
    J Biotechnol; 2006 Dec; 127(1):115-28. PubMed ID: 16904217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-factor, an essential regulatory substance inducing the production of rifamycin in a Nocardia sp.
    Kawaguchi T; Asahi T; Satoh T; Uozumi T; Beppu T
    J Antibiot (Tokyo); 1984 Dec; 37(12):1587-95. PubMed ID: 6526727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei.
    Gygax D; Ghisalba O; Treichler H; Nüesch J
    J Antibiot (Tokyo); 1990 Mar; 43(3):324-6. PubMed ID: 2324014
    [No Abstract]   [Full Text] [Related]  

  • 15. Ansamycin biogenesis: studies on a novel rifamycin isolated from a mutant strain of Nocardia mediterranei.
    White RJ; Martinelli E; Lancini G
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3260-4. PubMed ID: 4528428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiazorifamycins. III. Biosynthesis of rifamycins P, Q and verde, novel metabolites from a mutant of Nocardia mediterranea.
    Cricchio R; Antonini P; Sartori G
    J Antibiot (Tokyo); 1980 Aug; 33(8):842-6. PubMed ID: 7429988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of rifemycins production by Amycolatopsis mediterranei in batch and fed-batch cultures.
    El-Enshasy HA; Beshay UI; El-Diwany AI; Omar HM; El-Kholy AG; El-Najar R
    Acta Microbiol Pol; 2003; 52(3):301-13. PubMed ID: 14743983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel assay for screening rifamycin B-producing mutants.
    Vohra RM
    Appl Environ Microbiol; 1992 Jan; 58(1):403-4. PubMed ID: 1539986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation of rifamycin S into rifamycins B and L. A revision of the current biosynthetic hypothesis.
    Ghisalba O; Roos R; Schupp T; Nüesch J
    J Antibiot (Tokyo); 1982 Jan; 35(1):74-80. PubMed ID: 7200089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phosphate control to rifamycin SV biosynthesis].
    Ni LY; Chiao JS
    Wei Sheng Wu Xue Bao; 1988 Dec; 28(4):340-5. PubMed ID: 3247718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.